John F. Paolini, SVP & Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 21,593 shares at $18.29 ($395K) on 2020-02-13, disclosed to the SEC on 2020-02-18.
Open-market sale of $395k KNSA by SVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.29 | 10,277 | $188K | 47.6% |
| 2 | $18.29 | 10,277 | $188K | 47.6% |
| 3 | $18.33 | 1,039 | $19K | 4.8% |
| Total | $18.29 avg | 21,593 | $395K | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |